Membership
Tour
Register
Log in
Matteo Conza
Follow
Person
Thayngen, CH
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Processes for preparing a pan-JAK inhibitor and related intermediat...
Patent number
11,739,103
Issue date
Aug 29, 2023
Theravance Biopharma R&D LP, LLC
Norbert Kraut
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-...
Patent number
10,100,035
Issue date
Oct 16, 2018
JANSSEN PHARMACEUTICA NV
Diego Broggini
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-...
Patent number
9,796,699
Issue date
Oct 24, 2017
JANSSEN PHARMACEUTICA NV
Diego Broggini
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Process for the preparation of opioid compounds
Patent number
9,701,688
Issue date
Jul 11, 2017
Noramco, Inc.
Matteo Conza
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
Patent number
9,663,497
Issue date
May 30, 2017
JANSSEN PHARMACEUTICA NV
Matteo Conza
C30 - CRYSTAL GROWTH
Information
Patent Grant
Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
Patent number
9,434,715
Issue date
Sep 6, 2016
JANSSEN PHARMACEUTICA NV
Matteo Conza
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
Patent number
9,278,952
Issue date
Mar 8, 2016
JANSSEN PHARMACEUTICA NV
Matteo Conza
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Processes and intermediates for preparing a medicament
Patent number
9,156,847
Issue date
Oct 13, 2015
JANSSEN PHARMACEUTICA NV
Philip Pye
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
Patent number
8,859,575
Issue date
Oct 14, 2014
JANSSEN PHARMACEUTICA NV
Matteo Conza
C07 - ORGANIC CHEMISTRY
Patents Applications
last 30 patents
Information
Patent Application
PROCESSES FOR PREPARING A PAN-JAK INHIBITOR AND RELATED INTERMEDIAT...
Publication number
20220112219
Publication date
Apr 14, 2022
JANSSEN BIOTECH, INC.
Norbert Kraut
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SUBSTITUTED 2-[3-(1-METHYL-PIPERIDIN-4-YL)-PROPYLAMINO]-PYRIMIDINE-...
Publication number
20180009783
Publication date
Jan 11, 2018
Janssen Pharmaceutica N.V.
Diego Broggini
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SUBSTITUTED 2-[3-(1-METHYL-PIPERIDIN-4-YL)-PROPYLAMINO]-PYRIMIDINE-...
Publication number
20170121309
Publication date
May 4, 2017
Janssen Pharmaceutica N.V.
Diego Broggini
C07 - ORGANIC CHEMISTRY
Information
Patent Application
BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
Publication number
20160340337
Publication date
Nov 24, 2016
Janssen Pharmaceutica N.V.
Matteo Conza
C07 - ORGANIC CHEMISTRY
Information
Patent Application
BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
Publication number
20160159775
Publication date
Jun 9, 2016
Janssen Pharmaceutica N.V.
Matteo Conza
C30 - CRYSTAL GROWTH
Information
Patent Application
PROCESSES AND INTERMEDIATES FOR PREPARING A MEDICAMENT
Publication number
20150376193
Publication date
Dec 31, 2015
Janssen Pharmaceutica N.V.
Philip PYE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PROCESS FOR THE PREPARATION OF OPIOID COMPOUNDS
Publication number
20150315205
Publication date
Nov 5, 2015
Noramco, Inc.
Matteo Conza
C07 - ORGANIC CHEMISTRY
Information
Patent Application
BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
Publication number
20140364607
Publication date
Dec 11, 2014
Matteo Conza
C30 - CRYSTAL GROWTH
Information
Patent Application
PROCESSES AND INTERMEDIATES FOR PREPARING A MEDICAMENT
Publication number
20140275126
Publication date
Sep 18, 2014
Philip PYE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
Publication number
20140256942
Publication date
Sep 11, 2014
Janssen Pharmaceutica NV
Matteo Conza
C30 - CRYSTAL GROWTH